Preferred INR for On-X Aortic Valve
For patients with an On-X mechanical aortic valve and no thromboembolic risk factors, target an INR of 1.5-2.0 plus aspirin 75-100 mg daily starting 3 months after surgery. 1
Risk Stratification Determines INR Target
The 2020 ACC/AHA guidelines specifically address the On-X valve as a unique case among mechanical aortic valves, allowing for lower anticoagulation intensity than standard mechanical valves 1. The key decision point is the presence or absence of thromboembolic risk factors.
For Low-Risk Patients (No Risk Factors):
- INR goal: 1.5-2.0 plus aspirin 75-100 mg daily
- Start this regimen 3 months post-surgery
- This represents a Class 2b recommendation in ACC/AHA guidelines 1
For High-Risk Patients (With Risk Factors):
- INR goal: 2.5 (range 2.0-3.0) - same as standard mechanical valves
- If multiple or severe risk factors: INR goal 3.0 (range 2.5-3.5)
Thromboembolic risk factors include:
- Atrial fibrillation
- Previous thromboembolism
- Hypercoagulable state
- Left ventricular systolic dysfunction
- Older-generation prosthesis 1
Supporting Evidence for Lower INR
The PROACT trial 2 demonstrated that INR 1.5-2.0 with low-dose aspirin in On-X aortic valve patients resulted in significantly lower major bleeding (1.48% vs 3.26% per patient-year, P=0.047) and minor bleeding (1.32% vs 3.41% per patient-year, P=0.021) compared to standard INR 2.0-3.0, with no significant increase in thromboembolism. Mean follow-up was 3.82 years.
More recent observational data 3 from 510 patients with median 3.4-year follow-up showed the composite endpoint rate (thromboembolism, valve thrombosis, major bleeding) was 2.31% with INR 1.8 (range 1.5-2.0) versus 5.39% with standard dosing—a 57% reduction. Major bleeding decreased by 85% with no valve thrombosis events. A 2025 Chinese study 4 confirmed lower bleeding events with INR 1.5-2.0 without increased embolic events.
Critical Caveats and Pitfalls
Timing matters: The lower INR target should only begin 3 months after surgery, not immediately postoperatively 1. Initial anticoagulation should follow standard protocols.
Aspirin is mandatory: The lower INR strategy requires concurrent aspirin 75-100 mg daily—this is not optional 1, 3, 2. The combination provides adequate thromboprophylaxis while minimizing bleeding.
Individual variation exists: A case report 5 documented recurrent thromboembolic strokes in a 36-year-old with On-X valve despite INR 2.4, ultimately requiring INR 2.5-3.5. While rare, this highlights that some patients may need higher targets despite guideline recommendations.
Risk factor reassessment: Patients should be periodically re-evaluated for new thromboembolic risk factors (e.g., development of atrial fibrillation), which would necessitate increasing the INR target 6. Nearly 30% of patients in one stewardship initiative had INR goals inconsistent with their current risk profile.
Practical Implementation
- First 3 months post-op: INR 2.5 (range 2.0-3.0) for all patients
- After 3 months (if no risk factors): Reduce to INR 1.5-2.0 + aspirin 75-100 mg
- If risk factors develop: Increase to INR 2.5 (range 2.0-3.0) or INR 3.0 (range 2.5-3.5) depending on severity
- Home INR monitoring is effective: The lower INR strategy works equally well with home or clinic monitoring 3
The On-X valve's unique design allows for this reduced anticoagulation intensity, but this recommendation applies only to the On-X valve in the aortic position—other mechanical valves require standard INR targets of 2.5 (range 2.0-3.0) 1.